GlassScriptPhysician profile
Lauren B Messinger
NPI 1982970042
$1,703.03
in general payments reported to CMS, 2019-2025
22 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $170 · 2021: $101 · 2022: $636 · 2023: $287 · 2024: $66.68 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $300.27 | 2019-2023 | |
| Organon LLC | $291.20 | 2022 | |
| Astellas Pharma US INC | $215.76 | 2022-2025 | Veozah |
| Pfizer INC. | $131.66 | 2019-2022 | |
| Astellas Pharma Global Development | $118.45 | 2023 | Veozah |
| Ethicon US, LLC | $78.82 | 2025 | Enseal |
| Millicent US INC | $75.73 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $67.69 | 2022 | |
| Merck Sharp & Dohme LLC | $54.76 | 2019 | |
| Therapeuticsmd, INC. | $54.06 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.31 | 2022 | |
| Coopersurgical, INC. | $40.61 | 2023 | Paragard T 380a, Endosee |
| Duchesnay USA Incorporated | $37.63 | 2019 | |
| Biogen, INC. | $36.67 | 2023 | |
| Amag Pharmaceuticals, INC. | $34.41 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $29.78 | 2019 | |
| Sumitomo Pharma America, INC. | $24.17 | 2023 | Myfembree |
| Amgen INC. | $15.29 | 2019 | |
| Avion Pharmaceuticals | $14.66 | 2020 | |
| Currax Pharmaceuticals LLC | $14.21 | 2024 | Contrave |
| Minerva Surgical, INC | $13.44 | 2022 | |
| Olympus America INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Messinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.